Step 1 topics → Microbiology → Neisseria meningitidis and gonorrhoeae

Neisseria meningitidis and gonorrhoeae

USMLE Step 1 trap: Confuses maltose fermentation pattern between N. meningitidis and N. gonorrhoeae. N. meningitidis ferments both glucose and maltose, while N. gonorrhoeae ferments glucose only; this is the key lab distinction.

Neisseria meningitidis and N. gonorrhoeae are the two pathogenic Neisseria species, and USMLE Step 1 loves testing whether you can tell them apart — both clinically and in the lab. The single most reliable lab discriminator is maltose fermentation: N. meningitidis ferments both glucose and maltose, while N. gonorrhoeae ferments only glucose. They share a lot: both are gram-negative diplococci, both are oxidase-positive, both grow on Thayer-Martin media (chocolate agar with antibiotics that kill everything else), and both require the MAC (membrane attack complex) for clearance. The distinctions, though, are fair game at every level of the exam — from straight recall to clinical vignette interpretation.

The exam tests this topic from multiple angles. Identification questions pivot on lab features, especially maltose fermentation. Clinical questions probe your ability to recognize meningococcal disease complications (Waterhouse-Friderichsen, purpura fulminans, DIC) and the full spectrum of gonococcal disease across different populations — sexually active adults, neonates, and patients with disseminated infection. Resistance questions are increasingly high-yield as treatment guidelines have shifted away from fluoroquinolones entirely.

What makes this concept tricky is the overlap between the two organisms and the tendency to memorize surface-level facts without understanding mechanism. Students frequently mix up maltose fermentation, misattribute recurrent Neisseria infections to asplenia instead of complement deficiency, and still reach for fluoroquinolones on gonorrhea treatment questions despite widespread resistance. USMLE Step 1 specifically exploits these gaps, so knowing the right answer isn't enough — you need to understand why the wrong answers are wrong.

From real student decks
92%have cards covering this topic
81%have mature cards
1.0median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Both N. meningitidis and N. gonorrhoeae ferment maltose.
Right: N. meningitidis ferments both glucose and maltose, while N. gonorrhoeae ferments glucose only; this is the key lab distinction.
N. gonorrhoeae only ferments glucose — it cannot break down maltose. N. meningitidis ferments both glucose and maltose. This single biochemical difference is the classic lab distinction the exam uses to separate them, and it's easy to blank on under pressure. Build a hook: 'Meningitidis is More — it ferments More sugars (glucose + Maltose).' If you see a gram-negative diplococcus that ferments only glucose, that's gonorrhoeae.
Common mistake
Wrong: Asplenia is the primary risk factor for recurrent meningococcal disease.
Right: Terminal complement deficiencies (C5–C9) are the classic risk factor for recurrent Neisseria infections, including meningococcal disease.
Asplenia increases susceptibility to encapsulated bacteria (Streptococcus pneumoniae, H. influenzae, N. meningitidis) by impairing opsonization and clearance — but it does not cause recurrent Neisseria infections specifically. Terminal complement deficiency (C5–C9, the MAC) is the classic risk factor for recurrent infections with Neisseria species, because Neisseria are uniquely dependent on complement-mediated lysis for clearance. When a Step 1 vignette describes a patient with multiple episodes of meningococcemia or disseminated gonococcal infection, think complement deficiency first.
Common mistake
Wrong: Fluoroquinolones remain a reliable treatment option for gonorrhea.
Right: Fluoroquinolone resistance is widespread in N. gonorrhoeae; ceftriaxone (IM) is the current recommended treatment.
Fluoroquinolone resistance in N. gonorrhoeae became clinically significant in the 2000s and is now widespread enough that fluoroquinolones are no longer recommended as first-line or reliable therapy. The current standard is ceftriaxone IM (a third-generation cephalosporin). On USMLE Step 1, if an answer choice offers ciprofloxacin or levofloxacin for gonorrhea, it's wrong — the exam specifically tests whether you know this resistance pattern has changed clinical practice.
Common mistake
Wrong: Neonatal gonococcal conjunctivitis presents days to weeks after birth.
Right: Neonatal gonococcal ophthalmia neonatorum presents within the first 2–5 days of life, earlier than chlamydial conjunctivitis (5–14 days).
Gonococcal ophthalmia neonatorum presents within the first 2–5 days of life because N. gonorrhoeae is a fast-growing, highly virulent organism that causes intense purulent conjunctivitis rapidly after inoculation during delivery. Chlamydial conjunctivitis, by contrast, presents later — typically 5–14 days after birth — because Chlamydia trachomatis is an obligate intracellular organism with a slower replication cycle. When a Step 1 question gives you a 3-day-old with purulent eye discharge, think gonorrhea; at 10 days, think chlamydia.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given lab results (oxidase test, fermentation pattern, culture medium), identify whether an isolate is N. meningitidis or N. gonorrhoeae — the key distinguisher is maltose fermentation, which only meningitidis does.
  2. Recognize the systemic complications of meningococcal disease, including Waterhouse-Friderichsen syndrome (bilateral adrenal hemorrhage), purpura fulminans, DIC, and the patient population at highest risk for recurrent disease (terminal complement deficiency, C5–C9).
  3. Identify gonococcal disease across its full clinical spectrum: urethritis, cervicitis, PID, septic arthritis (most common cause of septic arthritis in sexually active young adults), and neonatal ophthalmia neonatorum — and distinguish it from chlamydial co-infection by timing, symptoms, and treatment.
  4. Select the correct treatment for gonorrhea given current resistance patterns — ceftriaxone IM is the answer; fluoroquinolones are no longer reliable due to widespread resistance, and azithromycin is often added empirically for chlamydia co-coverage.

Can you avoid these mistakes?

A lab report shows a gram-negative diplococcus isolated from CSF that ferments glucose but NOT maltose, and grows on Thayer-Martin agar. What organism is this, and how would the result differ if maltose fermentation were positive?
A 19-year-old man has had three separate episodes of bacterial meningitis caused by N. meningitidis over five years. His spleen is intact and he is otherwise healthy. What is the most likely underlying immunodeficiency, and what is the mechanistic reason this pathogen specifically recurs in this setting?
A sexually active 24-year-old woman presents with fever, migratory polyarthralgia, and a few pustular skin lesions on her extremities. Gram stain of joint fluid shows gram-negative diplococci. What is the diagnosis, what is the correct treatment, and why is ciprofloxacin not a good choice here?
A 4-day-old neonate presents with profuse bilateral purulent eye discharge. What is the most likely causative organism, what is the route of transmission, and how would the presentation differ if the same infant presented at 10 days of life?

Related topics

Encapsulated Organisms Bacterial Staining and Structure Bacterial Culture Requirements Bacterial Exotoxins

See how your Anki deck covers this topic.

Upload your deck for a free audit →